Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DiscoveRx Corporation has announced a collaboration with Caliper Life Sciences, which enables functional cell-based G protein-coupled receptor assays to be performed on Caliper LabChip platforms.
Subscribe to our email newsletter
The combined offering bundles the DiscoveRx’s cellular assays, such as PathHunter ß Arrestin and cAMP Hunter with LabChip systems to help pharmaceutical and biotechnology researchers more efficiently discover G protein-coupled receptor (GPCR) drugs.
Kevin Hrusovsky, CEO of Caliper Life Sciences, said: “This collaboration will expand the capability of Caliper’s LabChip technology into the dynamic GPCR drug discovery market, an opportunity with substantial potential due to the importance of GPCR drugs and the number of active R&D programs in neuroscience, cardiovascular, inflammation and other disease areas.”